Ziglim Mv 2

Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Uses of Ziglim Mv 2

Type 2 diabetes mellitus in adults when diet and exercise alone or single/dual therapy is insufficient; helps control post‑meal and fasting blood glucose

• •Lowers fasting and post-meal blood sugar
• •Improves insulin sensitivity
• •Reduces carbohydrate absorption after meals
• •Helps achieve better HbA1c control

How it works

Glimepiride (a sulfonylurea) increases insulin release from the pancreas. Metformin (a biguanide) reduces hepatic glucose production and improves insulin sensitivity. Voglibose (an alpha‑glucosidase inhibitor) delays carbohydrate absorption in the gut to reduce post‑meal glucose spikes.

Directions for use

Oral tablet. Take exactly as prescribed, usually once daily with or just after the main meal (often breakfast) to reduce stomach upset and hypoglycaemia risk. Swallow whole; do not crush/chew modified‑release tablets. Monitor blood glucose regularly.

Side effects

Common side effects of Ziglim Mv 2 may include:

• •Hypoglycaemia
• •nausea
• •vomiting
• •diarrhoea
• •abdominal pain
• •loss of appetite